TLSI
TriSalus Life Sciences Inc.
NASDAQ: TLSI · HEALTHCARE · MEDICAL DEVICES
$4.39
+1.62% today
Updated 2026-05-01
Market cap
$275.75M
P/E ratio
—
P/S ratio
6.11x
EPS (TTM)
$-1.84
Dividend yield
—
52W range
$3 – $8
Volume
0.2M
TriSalus Life Sciences Inc. (TLSI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-36.1%
Last 4 quarters
Revenue YoY growth
+59.8%
Most recent quarter
EPS YoY growth
+87.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.2%
2026-03-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-06 | $-0.05 | +61.5% | $4.77 | $4.62 | -3.2% |
| 2025-11-13 | $-0.96 | -481.8% | $4.42 | $4.56 | +3.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.13 | $-0.05 | +61.5% | $13.21M | +59.8% |
| 2025-09-30 | $-0.17 | $-0.96 | -481.8% | $11.57M | +57.4% |
| 2025-06-30 | $-0.22 | $-0.27 | -22.7% | $11.21M | +52.3% |
| 2025-03-31 | $-0.48 | $-0.40 | +16.7% | $9.17M | +42.0% |
| 2024-12-31 | $-0.35 | $-0.40 | -14.3% | $8.26M | +44.4% |
| 2024-09-30 | $-0.37 | $-0.40 | -8.8% | $7.35M | +41.5% |
| 2024-06-30 | $-0.46 | $-0.21 | +54.3% | $7.36M | +59.7% |
| 2024-03-31 | $-0.65 | $-0.60 | +7.7% | $6.46M | +116.4% |
| 2023-12-31 | $-0.69 | $-1.56 | -126.1% | $5.72M | — |
| 2023-09-30 | — | $-0.13 | — | $5.19M | — |
| 2023-06-30 | — | $-0.12 | — | $4.61M | — |
| 2023-03-31 | — | $-0.05 | — | $2.98M | — |
Frequently asked questions
Has TriSalus Life Sciences Inc. beaten earnings estimates?
TriSalus Life Sciences Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -36.1% over the last 4 quarters.
How does TLSI stock react to earnings?
TLSI stock has moved an average of -0.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is TriSalus Life Sciences Inc.'s revenue growth rate?
TriSalus Life Sciences Inc. reported year-over-year revenue growth of +59.8% in its most recent quarter, with EPS growing +87.5% year-over-year.